The European Food Safety Authority (EFSA) issued a scientific opinion on the safety and efficacy of Phileo’s yeast product Actisaf Sc47 last week. According to EFSA’s FEEDAP Panel, the additive has the potential to be efficacious in weaned piglets and sows but it could not conclude on the efficacy of the product for beef cattle and dairy cows from the data currently available.
“Actisaf Sc47 proved it efficacy extensively in dairy cows and beef in the market place for the past 30 years and is recognized by our customers on a global level for the benefits it brings to the animals and the production efficacy of the farms,” said Dr Eric Auclair, R&D director, Phileo Lesaffre Animal Care.
He said he fully understood EFSA protocols evolve to guarantee the safety and efficacy of all products on the EU market, and that new regulations around prove of efficacy within dossiers occurred during this re-authorization period.
Phileo is now set to complete the dossiers and provide new trial results to EFSA on the additive, said Auclair.
“Recent peer reviewed scientific publications describing innovative omics technologies proving the effect of Actisaf Sc47 in the nutrition of piglets, improvement in the transition cow and the reduction of the risk of NEBAL confirm the positive results we see in the market.
“The ongoing re-authorization process has no consequences for our European customers, the use of Actisaf in dairy cows and beef is fully authorized across Europe,” he added.
The company said the product is also registered for use in pigs for fattening, weaned piglets, sows, rabbits, fattening lambs, dairy goats, sheep, horses, dairy buffalos and calves for rearing.
